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Abstract. A narrow epidemiologic survey was conducted during a four-month period of intense malaria trans- 
mission in Dielmo, a holoendemic Senegalese village. Longitudinal clinical and parasitologic follow-up indicate that 
clinical malaria episodes always occurred after an abrupt increase in parasite densities. Polymerase chain reaction 
analysis of Plasmodium falciflaruin parasites was carried out in blood samples collected longitudinally from 10 
children who had experienced several clinical episodes during this period. Our data show that the genetic diversity 
of the parasites circulating in this village is very large. The successive clinical episodes experienced by each child 
were caused by genetically distinct parasite populations that were recently inoculated and multiplied in an apparently 
unrestricted manner. Importantly, the genetic characteristics of the parasite populations detected during phases of 
asymptomatic carriage differed from those causing a clinical episode, suggesting that the various factors that control 
of parasite growth in these children are strain-specific. 
In naive individuals, infection by malaria parasites almost 
invariably results in a clinical episode. In humans living in 
regions where malaria transmission is high, clinical malaria 
primarily affects young children and the presence of blood- 
stage parasites is not synonymous with disease. A significant 
proportion of young children, most older children, and many 
adults carry parasites without presenting clinical symptoms.' 
It is generally admitted that this reflects the efficiency of the 
progressively acquired malaria-specific immunity, which 
prevents clinical manifestations and reduces parasite burden. 
To date, little is known about how this protective immunity 
is elicited, how it operates, and how parasitization results in 
disease?. Experimental infections in humans with defined 
parasite strains have shown that an efficient strain-specific 
immunity was acquired after infection with one strain, al- 
lowing the individual to resist infection by that strain but 
providing little protection against a heterologous Sev- 
eral infections with the same strain were, however, required 
to elicit a sterile immunity to that   train.^ These findings 
showed that both poor immunogenicity and strain diversity 
may represent serious obstacles to the development of pro- 
tective immunity. The relevance of these observations to the 
situation faced by humans living in malaria-endemic regions 
is still obscure. While there is now ample evidence that ma- 
laria parasite species are polymorphic for a large number of 
characteristics,6 the extent of genetic diversity of local par- 
asite populations to which people are actually exposed is 
essentially unknown, and virtually nothing is known about 
the circulation of strains in a restricted geographic area.7.8 
Therefore, the question of whether parasite diversity plays a 
major role in the occurrence of clinical episodes in endemic 
regions, a key element in our understanding of hosdparasite 
relationships, is still unanswered. 
To address this issue, we have carried out an analysis of 
the genetic characteristics of Plasinodiuiiz falci~>aruin para- 
sites collected longitudinally from children who experienced 
several successive clinical episodes. In Dielmo, a Senegalese 
village where malaria is holoendemic, a close follow-up of 
the entire population of the village was carried out during 
the 1990 rainy s e a ~ o n . ~  As a result, longitudinal records of 
parasite densities of P. fakiparum, P. malariae, and P. ovale 
and of clinical events are available for each inhabitant of the 
village during this four-month period of high transmi~sion.~ 
The mean inoculation rate was approximately one P. falcip- 
arum infective bite every second night and most children 1- 
6 years of age experienced more than one clinical malaria 
episode. During this survey, capillary blood samples were 
collected at two-week intervals as well as during clinical 
episodes, allowing a longitudinal analysis of the character- 
istics of the parasites infecting the inhabitants of this village 
over a four-month period of intense malaria transmission. 
Plasmodium falciparuin parasites circulating in human pe- 
ripheral blood are haploid ring stages. We have carried out 
a typing procedure based on the polymerase chain reaction 
(PCR) that uses DNA from circulating parasites to analyze 
several single-copy genetic loci. The large allelic diversity 
reported in regions such as block 2 of the merozoite surface 
antigen-1 (MSA-1) gene or the central repetitive domain of 
the MSA-2 gene, differing both in nucleotide sequence and 
in number of repetitive sequences, or in the thrombospondin 
related anonymous protein (TRAP) gene, presenting restric- 
tion site polymorphism, renders these markers particularly 
convenient for typing purposes.10 Distinct parasite popula- 
tions can readily be identified using one or a combination 
of these characters.I0. II Such a typing approach was used in 
the work reported here to analyze the characteristics of P. 
fakiparum parasites collected from 10 children who had ex- 
perienced two or more clinical malaria episodes during the 
four-month period of intense follow-up in Dielmo. 
MATERIALS AND METHODS 
Study site. The Dielmo village is located in the Fatick 
region, 280 km southeast of Dakar, Senegal. After reaching 
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an agreement with the leaders and the population of the vil- 
lage, as well as with the national authorities, an epidemio- 
logic study was undertaken in June 1990. A detailed descrip- 
tion of Dielmo and of the epidemiologic study conducted in 
this village has been reported el~ewhere.~ Due to the pres- 
ence of a stream, malaria transmission is perennial. From 
June 1 to September 30, 1990, when the samples analyzed 
were collected, the inoculation rate was approximately one 
infective P. falciparum bite every second night. 
Longitudinal clinical and parasitologic follow-up. The 
clinical, parasitologic information reported here for 10 chil- 
dren was collected during the close follow-up of the entire 
population of the village (247 inhabitants) carried out from 
June 1 to September 30, 1990. Briefly, each person was vis- 
ited at home three times a week to record temperature (rectal 
temperature for the children less than seven years of age) 
and to administer a clinical questionnaire concerning the past 
48 hr. In addition, each compound was visited daily to rap- 
idly detect new cases of fever. Twice a week, a thick blood 
smear was made from each person in the village. In al1 pa- 
tients with fever, additional blood smears were taken. The 
thick blood smears were stained with Giemsa and at least 
200 oil-immersion fields were examined by microscopy. Par- 
asites were quantified as described by Trape and  other^.^.^^ 
Since parasite prevalence in the village was very high, a 
cutoff in parasite density was used to define malaria episodes 
and decide upon treatment. For children, a clinical malaria 
episode was defined as fever (rectal temperature 2 38.5"C) 
associated with a parasite:leukocyte ratio 2 2, i.e., 2 16,000 
parasites/p1.12 Treatment consisted in administration of Quin- 
imax@ (Sanofi-Labaz, Paris, France) at a dose of 25 mg/kg/ 
day in three daily doses over three days. As part of the pro- 
tocol, the Dielmo villagers were asked not to use chemopro- 
phylaxis or automedication without informing the team. Use 
of antimalarials by the population was indeed restricted to 
our prescriptibns, as indicated by questionnaire and monthly 
urine tests.9 
Collection of blood samples. Blood samples were col- 
lected twice a month using capillary pipettes and venous 
blood samples were collected during malaria attacks. The 
samples were centrifuged, the buffy coat was discarded, and 
the red blood cell pellet was frozen in liquid nifrogen in the 
village. After transportation, the tubes were stored at -80°C. 
The protocol was approved by the Ministere de la Cooper- 
ation et du Developpement and the Ministere de la Sante 
Publique of Senegal. IFformed consent was obtained indi- 
vidually from the participants or their parents. 
Extraction of DNA. Using standard procedures,1° DNA 
was extracted. Briefly, approximately 100 pl of red blood 
cells were lysed by three freeze-thaw cycles. Free parasites 
were washed three times with distilled water and resuspend- 
ed in five volumes of TEN buffer (10 mM Tris-HC1, pH 8.0, 
1 mM EDTA, 0.15 M NaCl), 0.5% Triton X 100, 0.5% so- 
dium dodecyl sulfate, and 5 mg/ml of proteinase K. After l 
hr of incubation at 37"C, the DNA was extracted twice with 
one volume of phenolkhloroforrdisoamyl alcohol (25/24/1), 
and precipitated with ethanol in the presence of 0.3 M so- 
dium acetate (pH 5.5). The DNA was resuspended in 50 p1 
of water. 
Amplification by PCR. The PCR procedures, permitting 
analysis of polymorphic regions of the MSA-1, MSA-2, and 
4 
TRAP loci, are detailed elsewhere.1° Briefly, amplification 
was done using 1-5 pl of DNA in a final volume of 50 pl 
in the presence of 200 pM of each dNTP, 1 pM of each 
primer, and 2.5 U of Taq I DNA polymerase (Promega 
France, Charbonnieres, France) in the buffer supplied by 
Promega (12 mM MgCl,). The reactions were performed in 
a Hybaid thermocycler (Cera-Labo, Aubervilliers, France). 
The standard reactions parameters were 15 sec at 94°C 2 
min at 55"C, 2 min at 72°C (one cycle), 2 sec at 94"C, 2 
min at 55"C, 2 min at 72°C (35 cycles), and 2 sec at 94"C, 
2 min at SOC, and 10 min at 72°C (one cycle). 
The primers used for MSA-1 were MSA-1 A: 5'AAG 
CTT TAG AAG ATG CAG TAT TGA C3' and MSA-1 B: 
5'ATT CAT TAA TTT CTT CAT ATC CAT C3'. For the 
MSA-2 gene the following primers were used: MSA-2 1: 
5'ATG AAG GTA ATT AAA ACA TTG TCT ATT ATA3' 
and MSA-2 2: 5'AAC GAA TTC ATA AAC AAT GCT TAT 
CAT GCA TAT GTC CAT GTT3' and MSA-2 4: 5'ATA 
TGG CAA AAG ATA AAA CAA GTG TTG CTG3'. For 
the amplification of the TRAP gene, the following primers 
were used: TRAP 3: 5'ATG TAA CTT GTA TGC TGA TTC 
TGC ATG G3' and TRAP 4: 5'TAT CTT CAC TAT TAG 
GTA CGT GCC TAT TTC C3'.lo 
Analysis of PCR products and allele assignment. The 
PCR products were analyzed for size polymorphism on aga- 
rose gels (Seakem GTG-Tebu France, Le Penray en Yvelines, 
France) as described.lo The TRAP alleles were identified by 
restriction fragment length polymorphism (FWLP) after di- 
gestion with Taq I restriction endonuclease.'O The MSA-1 
and MSA-2 alleles were assigned to allelic families by hy- 
bridization using family-specific probes, as described.lo 
Probes were prepared by nick translation (nick translation 
kit; Boehringer Mannheim, Meylan, France) using specific 
fragments amplified from reference clones or isolates, whose 
sequence has been determined or from the recombinant plas- 
mids obtained after cloning the various MSA-1 and MSA-2 
reference probes (TA cloning kit; In Vitrogen, Oxon, United 
Kingdom). A PCR product was assigned to a specific allelic 
family if it hybridized with the corresponding probe under 
stringent conditions (0.1X SSC 115 mM NaCl, 15 mM so- 
dium citrate, pH 7.01 at 65°C). The fragments that hybridized 
to one or more probe at moderate stringency (OSX SSC at 
65"C), but no longer at high stringency (0.1X SSC at 65°C) 
were considered hybrids. Fragments that hybridized to dis- 
tinct probes under conditions of low stringency (6X SSC at 
65"C), produced faint hybridization signals at higher strin- 
gency (2X SSC at 65"C), and did not hybridize under more 
stringent conditions were grouped as unassigned alleles. 
They most probably consisted of complex mosaic hybrid 
genes. lo 
AAT ATG AGT3'; MSA-2 3: 5'GAT GAA TTC TAG AAC 
RESULTS 
A total of 132 P. falciparurn clinical malaria episodes 
were observed ìn the 247 inhabitants of Dielmo. Most 
(92.6%) occurred in children less than 10 years of age. Ba- 
bies and children less than four years old experienced a 
mean of two clinical attacks, while older children (5-9 years 
of age) had a mean of one clinical attack? In the birth to 6- 
year-old group, 34 (61%) of 56 children had more than one 
" 4 ., 
634 
I 
CONTAMIN AND OTHERS 
clinical attack. None of the children more than seven years 
of age experienced more than one attack.I3 
The longitudinal parasitologic follow-up conducted during 
this period showed that malaria attacks were always asso- 
ciated with an abrupt increase in parasite density. In most 
cases, drug treatment resulted in rapid resolution of symp- 
toms and clearance of asexual blood stages in the first few 
days. This is illustrated in Figures 1-6, in which the longi- 
tudinal records of parasite densities of the children studied 
are presented. 
In this work, we have investigated some genetic charac- 
teristics of P fakiparum parasites collected longitudinally 
from children who had experienced two or more clinical 
episodes during the study period. Ten representative chil- 
dren, who presented between clinical episodes blood smears 
that were either 1) constantly negative or 2) constantly pos- 
itive, but with low parasite densities (trophozoites andlor ga- 
metocytes), were chosen. A total of 89 DNA preparations 
were made, including 28 from P. falciparunz clinical malaria 
episodes. The PCR typing was carried out for three distinct 
genetic loci located on distinct chromosomes.I0 For MSA-1 
(also called MSP-I), the highly polymorphic block 2 was 
amplified. For MSA-2 (also called MSPr2), two independent 
reactions were done, amplifying the entire coding region 
(primers 1 + 4) or the central polymorphic domain (primers 
2 + 3). The TRAP amplification concerned the central re- 
gion of the gene. All PCR primers used here were highly 
specific for P. fakiparum parasites, as tests with other hu- 
man malaria species did not yield any PCR product.Io Anal- 
ysis of the amplified fragments was done by investigating 
size polymorphism in all cases, and RFLP was investigated 
for the TRAP reaction. Both MSA-1 and MSA-2 fragments 
were assigned to specific allelic families (MAD 20, K1, and 
R033 for MSA-I and 3D7 and FC27 for MSA-2) by hy- 
bridization using family-specific probes. lo 
Analysis of the parasites collected during successive 
malaria episodes. We first analyzed the clinical episodes of 
children presenting constantly negative smears between the 
attacks. A typical example is illustrated in Figure 1, showing 
parasite typing from a 1.5-year-old girl, code 02/04, who 
experienced two clinical malaria episodes (arbitrarily des- 
ignated A and B in Figure l), with high parasite densities, 
both of which were successfully drug-treated. Apart from the 
smears collected during the attacks or for the following 2-3 
days, all thick blood smears collected from this child were 
negative. Eight successive blood samples (numbered 1-8) 
were available. The DNAs 1-3 and 6-7 were collected as 
part of the s'ystematic survey, and the corresponding thick 
blood smears were negative. The PCR from these samples 
was also negative for all markers investigated (Figure 1, 
lanes 1-3 and 6-7, respectively), Figure 1 shows that DNAs 
4 and 5, collected two days apart during episode A, pre- 
sented the same amplification patterns for MSA-1 and MSA- 
2, with two bands for each marker. The pattern obtained for 
DNA 8, collected during episode €3, however, produced a 
single band of a different size for both reactions. Assignment 
to specific allelic families was done by hybridization using 
family-specific probes,Io as summarized in Table 1. The 
MSA-1 fragments generated from DNAs 4 and 5 hybridized 
with the K1 family-specific probe, while the fragment ob- 
tained from DNA 8 hybridized with the MAD20 family- 
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FIGURE 1. Course of Plasmodium fakiparum parasitemia (top) 
and typing of the parasites (bottom) collected from child 02/04, a 
1.5-year-old girl, who experienced two clinical attacks, denoted A 
and E. Thick blood smears were collected twice a week. Positive 
thick blood smears contained exclusively P. fakiparum trophozoites. 
Parasite densities are expressed as the number of P. fakiparum tro- 
phozoites for 100 leukocytes (i.e., 1150-U100 IJ-I of blood). DNAs 
were prepared from blood samples collected on June 4 (l), June 22 
(2), July 9 (31, July 26 (4, episode A), July 28 (S), August 10 (6), 
August 24 (71, and September 29 (8, episode B). Clinical episodes 
were drug-treated, as described in the Materials and.Methods. Num- 
bers with an asterisk indicate that the corresponding thick blood 
smear was positive, while for the others, thick blood smears were 
negative. Bottom, analysis of the polymerase chain reaction (PCR) 
products by electrophoresis on agarose gels and staining with ethid- 
ium bromide. I, amplification of merozoite surface antigen- 1 (MSA- 
1) using primers A + B. II, amplification of MSA-2 using primers 
2 + 3; III and IV, typing for thrombospondin related anonymous 
protein (TRAP), undigested, and Tuq I-restricted PCR products, re- 
spectively. The numbers above each lane refer to the number of the 
DNA sample analyzed. O = no DNA added in the reaction; + = 
positive control (DNA from clone 89F5).18 The positions of the mo- 
lecular weight markers (Boehringer Mannheim marker VI) are in- 
dicated schematically for the 1,033-, 653-, 517-, 453-, 394-, and 
298-basepair (bp) markers in I and II. The size of the TRAP frag- 
ment is indicated in III. 
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FIGURE 2. Course of Plasmodium falciparum parasitemia in four children. Each clinical episode was drug-treated as described in the 
Materials and Methods. The symbols used are as in Figure 1. 14/05, a six-year-old boy, experienced four clinical episodes. The child carried 
exclusively P. falciparum trophozoites. Blood samples were collected on June 20 (1, episode A), July 9 (2), July 11 (3, episode B), July 28 
(4). August 6 (5, episode C), August 20 (6). September 1 (7, episode D), September 3 (8), and September 17 (9). 19/09, a three-year-old boy, 
experienced three clinical episodes. Blood samples were collected on June 23 (I), July 3 (2, episode A), July 7 (3), July 21 (4). July 25 (5, 
episode B), August 4 (6), August 18 (7), and August 19 (8, episode C). The child presented occasionally, in addition to the P. falciparum 
asexual blood stages indicated by an asterisk, low densities of P. fakiparum gametocytes (samples 1, 3, 4, and 5) and/or P. malariae (samples 
1 and 2) parasites during the period under study. 14/14, a four-year-old boy, experienced four clinical episodes. Blood samples were collected 
on June 4 (l), June 22 (2, episode A), July 8 (3, episode B), July 9 (4), July 28 (5, episode C), July 30 (6), August 6 (7), August 20 (8, 
episode D), September 3 (9), and September 21 (IO). The chiId presented, in addition to the P. fakiparum trophozoites indicated, low densities 
of P. malariae (samples 1, 2, and 3) and P. ovale (sample 2) parasites. 08/03, a five-year-old boy, experienced two clinical episodes. Blood 
samples were collected on June 30 (l), July 10 (2, episode A), July 16 (3, episode B), and July 25 (4). The child also carried low densities 
of P. falciparum gametocytes in a11 samples used for DNA extraction. 
specific probe. Both DNAs 4 and 5 generated MSA-2 frag- 
ments belonging to the FC27 allelic family,, and the single 
fragment amplified from DNA 8 was a 3D7-type. TRAP 
typing (Figure 1, bottom panel) confirmed that the parasites 
from both episodes were genetically distinct, since the alleles 
carried could be differentiated by Taq I R E E  
As shown in Figure 2, three other children (14/05, 19/ 
09, and 14/14) presented negative smears in the periods 
separating two attacks. Again, no PCR product was ob- 
tained from the samples with negative blood smears. Typ- 
ing of parasites in the samples collected during clinical ep- 
isodes is indicated in Table 1. Child 14/05, a six-year-old 
boy, experienced four episodes (designated A-D in Figure 
2). Typing of these episodes (Table 1) indicated that epi- 
sodes A and B could be easily distinguished both from each 
other, and from C and D by their TRAP, MSA-1, and MSA- 
2 markers. Parasites C and D could not be distinguished 
using MSA-1 nor TRAP, but MSA-2 typing showed that 
they were different, since DNA from episode C did not 
yield any band using primers 2 + 3 and no signal was 
obtained upon hybridization. Since this DNA generated a 
PCR product for the other markers used, including MSA-2 
using primers 1 + 4, we concluded that the sequence of 
the MSA-2 allele from episode C was such that primers 2 
+ 3 did not form stable hybrids. In  contrast, amplification 
using primers 2 + 3 was obtained from DNA collected in 
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FIGURE 3. Course of parasitemia and typing of the parasites from 
child 14/07, a two-year-old boy, who experienced four clinical epi- 
sodes, which were drug-treated as described in the Materials and 
Methods. Treatment of episode A was incomplete due to vomiting. 
Blood samples were collected on the dates indicated. The course of 
parasitemia is indicated using the same symbols as in Figure 1. The 
child carried exclusively Plasmodiuriz falciparurn parasites during this 
period. Gametocytes were detected occasionally; none of the samples 
used for DNA extraction contained gametocytes. Results of amplifi- 
cation of merozoite surface antigen-1 using primers A + B and MSA- 
2 using primers 2 t 3 are shown in I and II, respectively. Fragment 
size was estimated on agarose gels, using Boehringer Mannheim mo- 
lecular weight marker VI. The positions of the markers are indicated 
(from top to bottom: 1,033, 653, 517, 453, 394, and 298 basepairs 
[bp]). The numbers above each lane refer to the number of the DNA 
analyzed. O = no DNA added in the reaction: + = positive control 
(DNA from clone 89F5).18 The bottom of the figure summarizes gen- 
otyping. troph. indicates parasitemia, expressed as the number of tro- 
phozoites/100 leukocytes. The assignment to allelic family was carried 
out by hybridization using family-specific probes under conditions of 
distinct stringency, as described in the Materials and Methods. The 
various alleles observed are indicated in the same order for size and 
allelic type. -indicates that no fragment was observed, neither by stain- 
ing with ethidium bromide nor after hybridization. 
episode D, which also contained multiple MSA-2 alleles 
detected by hybridization. 
Child 19/09, a three-year-old boy, experienced three epi- 
sodes (A-C in Figure 2). During each, as indicated in Table 
1, the child had multiple parasite types, yielding three frag- 
ments for MSA-1, one or two fragments for MSA-2, de- 
pending on the primer combination used, and a single TRAP 
fragment. The MSA-1 types of episodes A and B could not 
be distinguished, while the alleles present during episode C 
differed from those detected in the previous ones. Parasites 
from each episode had a different TRAP pattern and a spe- 
cific MSA-2 profile. 
Child 14/14, a four-year-old boy, experienced four malaria 
episodes and had several negative blood smears in the period 
separating these episodes (Figure 2). Table 1 shows that each 
episode presented a specific TRAP allele and a unique mul- 
tiple band pattern for both MSA-1 and MSA-2. 
Other children presented negative blood smears shortly 
after treatment but could, thereafter, harbor parasites for sev- 
eral days or weeks without presenting symptoms before ex- 
periencing another clinical malaria episode. Typical exam- 
ples are illustrated in Figures 3-6. Comparison of the genetic 
characteristics of the parasites collected during the succes- 
sive episodes experienced by these children, indicated in Ta- 
ble l, again shows that the parasites collected during suc- 
cessive clinical episodes in a given child were genetically 
different. Episodes A, B, and C in child 28/06 differed in 
their MSA-2 profiles, as did episodes A and B experienced 
by child 02103. Episodes A and B in child 12/07 differed in 
their MSA-2 alleles and their TRAP profiles. For both epi- 
sodes in child 22/06, parasites differed at the three loci in- 
vestigated. 
There were two cases in which drug treatment did not 
result in complete clearance of the sexual blood stages with- 
in the following few days. As shown in Figure 2, treatment 
of episode A experienced by child 08/03 was followed by a 
32-fold decrease in parasite density but not by clearance, 
since parasites were detected in the three blood smears pre- 
ceding the outgrowth provoking episode B. Typing of the 
parasites from episodes A (DNA 1) and B (DNA 3) shown 
in Table 1 indicated that for these episodes, the parasites 
could not be distinguished. Sample DNA 2, collected during 
the interval, produced the same pattern, while DNA 4, ob- 
tained after drug clearance of peak B, was negative. The 
results of typing are consistent with a typical recrudescence 
due to incomplete treatment of the first episode. 
An analogous situation was observed for episodes A and 
B of child 14/07, a two-year-old boy. As shown in Figure 3, 
parasitemia in this child fluctuated during the month of June, 
while he remained asymptomatic. A rapid increase in para- 
site density resulted in a clinical episode on June 27 (episode 
A). Drug treatment of this episode was incompletely admin- 
istered (due to vomiting) and the child did not clear the 
parasites. A second clinical episode (B) was recorded a few 
days later on July 3. Treatment of this episode was complete 
and the following routine thick blood smears were negative. 
As shown in Figure 3, I and II, the DNAs collected during 
episodes A and B generated the same 580-basepair (bp), 
3D7-type MSA-2 allele, and both generated a 470-bp, K1- 
type MSA-1 allele. Parasites from episode A, however, gen- 
erated an additional MSA-1 band, typed as a 420-bp 
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FIGURE 4. Course of Plusniodiirnt fulcipurum parasitemia and typing of the parasites from child 28/06, a six-year-old boy, who experienced 
three clinical episodes, which were drug-treated as indicated in the Materials and Methods. The course of parasitemia is indicated using the 
same symbols as in Figure 1. The child presented, in addition to the P. falcipuncrit asexual blood stages indicated here, low densities of P. 
fulcipurum gametocytes (samples 4 and 8) and P. muluriue parasites (samples 1, 2, 3, 7, 8, and 10) during the period under study. Blood 
samples were collected on the dates indicated in the tabular portion of the figure, which summarizes the results from the typing of the merozoite 
surface antigen-1 (MSA-1) fragments amplified using primers A + B and of the MSA-2 fragments obtained using primers 2 + 3 and 
thrombospondin related anonymous protein (TRAP). troph. indicates parasitemia, expressed as the number of trophozoitesI100 leukocytes. The 
size of the fragments was estimated using Boehringer Mannheim molecular weight marker VI. The allelic type assigned to the various fragments 
detected is indicated, as deduced from hybridization using family-specific probes under conditions of distinct stringency, as described in the 
Materials and Methods. The various alleles observed are indicated in the same order for size and allelic type. Hybrid genes are indicated in 
parentheses. The TRAP typing was done using size polymorphism and Tuq I restriction fragment length polymoxphism. The varíous TRAP 
profiles have been assigned arbitrary codes, a-d. bp = basepairs; ? = ambiguous typing results (unassigned allele), - = no fragment observed. 
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FIGURE 5. Course of Plasinodiunz falciparum parasitemia and 
typing of the parasites from child 02/03, a four-year-old girl, who 
experienced two clinical episodes that were drug-treated as described 
in the Materials and Methods. The child carried P. falciparum tro- 
phozoites (troph.) and P. falciparum gametocytes (dotted line), as 
indicated. In addition, a low density of P. malariae parasites was 
observed in sample 1. Note that the scales used for trophozoites and 
gametocytes differ. Nine blood samples, numbered 1-9, were col- 
lected on the dates indicated. For definitions of the symbols used, 
see Figure 1. Results of amplification of merozoite surface antigen- 
1 (MSA-1) using primers A + B and MSA-2 using primers 1 t 4 
are shown in I and II, respectively. The numbers above each lane 
refer to the number of the DNA analyzed. O = no DNA added in 
the reaction; 4- = positive control (DNA from clone 89F5).18 Ge- 
notyping is also indicated. Parasitemia is expressed as the number 
of trophozoites/lOO leukocytes. For size determination and allele 
assignment, see Figure 3. 
MAD20-type, identical to the one detected from DNA 1, 
collected during the asymptomatic period preceding episode 
A. While typing indicated that the parasite populations pres- 
ent during episodes A and B were different, the results sug- 
gested that in both episodes, the parasites causing the pa- 
thology were those carrying the 470-bp K1 type. This 
prompted us to analyze the other symptomatic episodes in 
the context of the preceding asymptomatic carriage. 
Comparison of parasites carried before and during 
clinical attacks. The parasites carried by some children in 
the asymptomatic period preceding an attack were compared 
with those collected during the clinical episode. In addition 
to episodes A and B of child 14/07 noted above, this was 
also carried out for several episodes in three other children. 
The parasites from the three episodes experienced by child 
28/06 were compared with those collected in the preceding 
periods. As shown in Figure 4, DNA 2 yielded two distinct 
FC27-type MSA-2 fragments of 840 bp and 780 bp. From 
DNA 3, collected five days later during episode A, a single 
840-bp MSA-2 band was generated, suggesting that the peak 
parasitemia was due to multiplication of this parasite type 
that became dominant. In contrast, DNA 7, collected during 
episode B, was more complex than DNA 6, collected nine 
days earlier. The B clinical attack was associated with the 
detection of three MSA-1 and three MSA-2 fragments. 
Staining agarose gels with ethidium bromide indicated that 
this parasite population contained a mixture of (at least) 
three distinct types present in a similar proportion. Two 
MSA-1 alleles (a 460-bp K1-type and a 350-bp, MAD 20- 
type) amplified from DNA 7 were not observed in the pre- 
vious sample. Conversely, the 480 bp K1-type allele oh- 
served in sample 6 was not detected in DNA 7. Similarly, 
the 940-bp and the 870-bp 3D7iFC27 hybrids amplified from 
DNA 6 were no longer observed among the products ob- 
tained from DNA 7, while two new alleles, (a 940-bp 3D7- 
type and a 820-bp FC27-type), were generated from DNA 
7. This indicates that the parasite population collected at the 
time of the B clinical attack contained novel parasite geno- 
types, but did not contain a single dominant type. Similarly, 
the patterns generated from DNA 10, collected during epi- 
sode c, were more complex than those of the sample col- 
lected 12 days earlier, at a time when the child was asymp- 
tomatic (DNA 9). The DNA from episode C generated, in 
addition to the single MSA-1 or MSA-2 allele observed in 
DNA 9, two MSA-1 alleles (a 410-bp K I N A D  20 hybrid 
and a 350-bp MAD20 allele), and one additional 920-bp 
3D7-FC27 hybrid MSA-2 allele. In both reactions, however, 
the intensities of the ethidium bromide staining differed, the 
prominent bands being the 460-bp KI MSA-I allele and the 
920-bp MSA-2 hybrid, suggesting that there was a single 
dominant type in DNA 10. 
Figure 5 shows the course of parasitemia in child 02/03, 
a four-year-old girl, who experienced two malaria episodes 
associated with symptoms and high parasitemia, designated 
A and B. The other peaks of parasitemia were not febrile 
and decreased without treatment. The child carried P. fal- 
ciparurn gametocytes most of the time, All samples used for 
DNA preparation contained gametocytes, which complicated 
interpretation of the typing. Results obtained using MSA-1 
and MSA-2 1 + 4 primers are shown in Figure 5, I and II, 
respectively. A 380-bp K1-type MSA-1 fragment was ob- 
served in all samples, including those collected after Quin- 
imax@ treatment, in which only a few gametocytes and no 
asexual forms could be detected. This fragment is, therefore, 
interpreted as being derived from the same population of 
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FIG& 6. Course of Plusnzodium fulciparum parasitemia and typing of the parasites from child 22/06, a two-year-old girl, who experienced 
two clinical episodes, designated A and B, which wene drug-treated as described in the Materials and Methods. The child carried P.falcipurrtn2 
trophozoites and P. fakiparum gametocytes (dotted line), as indicated. Note that the scales used for trophozoites and gametocytes differ. For 
definitions of the symbols used, see Figure 1. Nine 'blood samples, numbered 1-9, were collected on the dates indicated. Typing results are 
summarized in the tabular portion of the figure. troph. refers to the number of trophozoites/lOO leukocytes. bp = basepairs. TRAP = throm- 
bospondin related anonymous protein. For size determination and allele assignment, see Figure 3. ' 
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TABLE 1
Genotyping of Plasmodium fulcipururn parasites from successive clinical episodes in 10 children* 
-ab+-- 
P. fulci- 
punirti 
MSA-! A + B MSA-I block 2 MSA-2 1 + 4 MSA-2 TRAP 
allelic family SlZC allelic family profile 
Agc Clinical tropho- 
Child (years) episode Date zoitest size 
648 520 + 420 K1, K1 880 + 820 FC27, FC27 02/04 1.5 A 7/26/90 a 
732 . ,560 MAD20 800 3D7 b B 9/29/90 
14/05 6 A 6/20/90 a 
X . 740 FC27 b B 711 1/90 1,300 410 
C 8/6/90 630 490 KI 920 X C 
920 FC27,3D7,3D7 D 9/1/90 584 490 K1 C 
(3D7, FC27) A 7/3/90 1,600 440 + 410 + 380 (KI, MAD20), MAD20, ? , 870 
b 3D7, (3D7, FC27) B 7/25/90 500 440 + 410 + 380 (KI, MAD20), MAD20, ? . 
(3D7, FC27) C 8/19/90 400 480 + 460 4- 440 ?, ?, KI 820 C 
14/14 4 A 6/22/90 a 
b 3D7, FC27 B 
C 7/28/90 1,500 430 + 310 4- 290 K1, MAD20, MAD20 
a 
500 430 (MAD20, KI) 780 3D7 d D 8/20/90 
B 8/15/90 236 460 + 410 + 350 KI ,  (KI, MAD20), MAD20 
C 9/15/90 1,100 460 + 410 + 350 KI, (Kl, MADZO), MAD20 
1,500 470 + 380 x, x 780 740 FC27,3D7 
19/09 3 a 
980 + 840 
370 430 MAD20 920 3D7 
n 
O 7/8/90 1,500 410 + 360 + 310 KI, MAD20, R033 920 + 750 
C 780 (3D7, FC27) z 
B 
920 + 840 (3D7, FC27), FC27 d 2 
7/4/90 729 430 KI 840 FC27 28/06 6 A 
P 940 + 820 + 780 3D7, FC27, FC27 ' C  
440 + 380 MAD20, KI 680 FC27 NA 02/03 4 A 6/30/90 1,027 
12/07 1 A 
B 7/30/90 400 440 + 380 MAD20, KI 760 3D7 NA s 
B 7/5/90 655 480 + 420 + 400 (MAD20, KI), R033, (MADZO, KI) 840 i- 800 FC27, FC27 b E 
22/06 2 A a 
08/03 5 A a 
B a 
B a 
a i5 6/23/90 663 480 + 420 f 400 (MAD20, KI), R033, (MADZO, KI) 940 + 800 FC27, FC27 
6/27/90 3,400 440 MAD20 900 + 830 3D7,3D7 
6/30/90 260 390 (Kl, R033) 880 FC27 
711 6/90 246 390 (Kl, R033) 880 FC27 
7/3/90 1,180 470 KI 580 3D7 
410 + 390 (KI, R033) 900 3D7, FC27 b B 9/2/90 270 
K1, MAD20 580 3D7 NA 
1,046 570 + 520 + 470 KI 580 doublet 3D7, FC27 NA 
14/07 2 A 6/27/90 830 470 + 420 
C 7/23/90 
D 9/22/90 1,306 540 MAD20 650 + 450 FC27, FC27 b 
*Episodes were arbitrarily coded A-D for each child. The size of the fragment is expressed in basepairs. The assignment to a specific allelic family was based on the results of hybridizaiton using allele-specific probes as described in the Materials 
and Methods. Hybrid genes (intragenic recombinants) hybridized with two distinct probes under nonstringent conditions and failed to hybridize with any of the probes at high stringency. They are indicared in parentheses. MSA-I = merozoite surface 
antigen-I. x = alleles that failed to hybridize under nonstringent conditions. ? = unassigned alleles duc to ambiguous hybridization results. (Sequencing indicnted thzit they are colnplex mosaic forrns of previously described allelic types). The 
thrombospondin related anonymous protein (TRAP) typing was done as described in the Malerials and Methods. Arbitrary codes (a-d) Irave been given for each series of samples analyzed from a child. N A  = not available. 
'I Values arc thc number of tropllozoitcsllO0 leukocytes. 
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gametocytes carried throughout the period under study. No 
specific MSA-2 allele could be associated with these ga- 
metocytes, probably because of insufficient sensitivity of the 
detection. The genetic characteristics of the parasites carried 
asymptomatically before each clinical episode could be com- 
pared with those of the parasites collected during the epi- 
sode. Sample DNA 3, collected during episode A, clearly 
differed from DNA 1. Interestingly, a 440-bp MAD 20-type 
MSA-I allele, barely visible in the products obtained from 
DNA 2 as shown in Figure 5, gave a strong dominant signal 
in DNA 3, suggesting that the parasites present at high den- 
sity and causing episode A were present in low amounts 
(below the level of microscopic detection) eight days before. 
This is consistent with a > lo3 increase in parasite density 
observed within that period. Sample DNA 6, collected dur- 
ing episode B, differed from DNA 5 collected six days ear- 
lier, in presenting a less complex picture: a 360-bp KI-type 
MSA-1 fragment present in DNA 5 could not be detected in 
DNA 6, suggesting that again the parasites causing episode 
B contained a dominant type. An additional peak of para- 
sitemia (DNA 9), not febrile but associated with headache, 
also corresponded with the presence of parasites that had not 
been detected before, characterized by a 290-bp MAD 20- 
type MSA-1 allele and a 620-bp FC27-type MSA-2 allele. 
In this child, the peaks of parasitemia, whether febrile or 
not, were therefore associated with detection in the periph- 
eral circulation of novel genotypes, distinct from those ob- 
served during asymptomatic carriage. 
The detection of novel genotypes during one episode was 
also observed in the analysis of parasites from child 22/06. 
The course of parasitemia in this two-year-old child, who 
also carried gametocytes most of the time, and typing of the 
parasites are shown in Figure 6. Three DNA samples (3, 4, 
and 5) were collected during the period spanning from epi- 
sode A (DNAs 1 and 2) to episode B (DNA 7). Both DNAs 
1 and 2 generated a 440-bp MAD 20 MSA-1 allele and 900- 
bp and 830-bp MSA-2 alleles of the 3D7-type in similar 
proportions, suggesting that this sample contained a mixture 
of two parasite types presenting indistinguishable MSA- 1 
alleles. Sample DNAs 3 and 4 yielded identical MSA-1 pro- 
files and the same MSA-2 allele, whereas DNA 5, collected 
from a sample containing gametocytes and no ,microscopi- 
cally visible trophozoites, contained a single MSA- 1 allele 
typed as a 410-bp K1-R033 hybrid. No MSA-2 allele could 
be amplified from this sample, probably due to low parasite 
density. Sample DNA 6 ,  collected four days before episode 
B, generated the same pattern as DNA 7, collected during 
episode B: 410-bp and a 390-bp K1-R033 MSA-1 hybrids. 
The 390-bp fragment was more abundant in the products 
amplified from DNA 7 than in those generated from DNA 
6, suggesting that episode B was caused by the parasites that 
carried this allele. 
DISCUSSION 
Data described in this report as well as im other molecular 
studies of parasites from Dielmolo. 14. indicate that genetic 
diversity of P. falciparum parasites circulating in this village 
is quite large. So far, the only cases in which identical PCR 
patterns have been observed were DNA samples collected a 
few days apart during the same clinical episode or during a 
4 
recrudescence resulting from incomplete parasite clearance 
after treatment of the first episode, i.e., cases where the par- 
asites are predicted to present identical genetic characteris- 
tics. This indicates that the technique used is reliable both 
qualitatively and quantitatively and that distinct PCR pat- 
terns do indeed reflect intrinsic genetic differences. The PCR 
typing approach used does not allow determination of the 
karyotype, and thus we do not know the actual number of 
distinct clones present in the isolates studied nor the precise 
gene combination of each of these clones. However, the re- 
sults unequivocally show that the parasite populations differ 
in the majority of isolates analyzed so far. All major allelic 
forms of the MSA-1 and MSA-2 genes described in the lit- 
erature (for a review, see the report by Kemp and others6] 
have been detected in the village. In the present study, 34 
distinct MSA-1 alleles and 31 distinct MSA-2 alleles were 
observed. In a cross-sectional study of asymptomatic carri- 
ers, carried out using samples collected during the 1992 
transmission season, 23 distinct MSA-2 alleles have been 
detected.I4 These are minimal estimates, since DNA se- 
quencing is likely to detect additional differences. 
In Dielmo, clinical malaria could be associated with par- 
asite densities above an age-dependent threshold, determined 
as 275 trophozoites/100 leukocytes at one year of age, de- 
creasing to 191 trophozoites/lOO leukocytes by the age of 
six years.I6 In all cases investigated, such levels were 
reached after a very rapid increase in parasite density, sug- 
gesting unrestrained parasite growth. The genetic character- 
istics of the parasite populations collected during a malaria 
episode differed from those detected in the blood sample 
collected in the preceding period. The PCR prafiles were 
either less complex, suggesting outgrowth of a dominant 
population or inversely more complex, indicating the pres- 
ence of additional parasite alleles and thus of additional par- 
asite types. Whether these are dominant is difficult to deter- 
mine in complex allelic mixtures.I0 Overall, however, the 
complexity of the infections, reflected by the number of dis- 
tinct alleles detected, was lower during the clinical episodes 
than during the phases of asymptomatic carriage. The mean 
number of MSA-2 alleles detected here in DNAs collected 
from clinical episodes was 1.4 per sample, while it was 4 in 
DNAs collected from children who remained asymptomatic 
during a similarly high transmission season.14 This is not a 
general rule because complex populations have also been 
observed in samples collected during a malaria episode.lo 
The trend is, nevertheless, clearly for less complex infections 
during a clinical episode than during asymptomatic camage. 
We interpret this as indicating that a dominant population is, 
in fact, responsible for the observed clinical event. 
Comparison of the genotypes of the parasites collected 
during the successive clinical episodes experienced by a 
child showed that the parasite populations collected from the 
peripheral circulation were different for each episode. As 
summarized in Table 2, this was observed in three children, 
who experienced two episodes, in two children who had 
three clinical attacks, and in three children who had four 
clinical malaria episodes during this four-month period of 
intense transmission. The single case in which the genotypes 
of two successive episodes could not be distinguished using 
the four typing reactions used here was interpreted as a re- 
crudescence. Since each episode was treated with quinine, 
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TABLE 2
Comparison of the merozoite surface antigen-1 (MSA-I), MSA-2, and thrombospondin related anonymous protein (TRAP) polymerase chain 
reaction pattems of the parasite population collected during successive clinical episodes in 10 children. The specific pattems (number of 
bands, size of the fragment, and allelic type) obtained for the parasite population collected during successive clinical episodes, coded A-D, 
have been compared* 
Child MSA-I block 2 MSA-2 central domain TRAP cenrral domain 
02/04 A # B  A # B  A # B  
14/05 A # B # C = D  . A # B # C # D  A # B # C = D  
19/09 A = B # C  A # B # C  A # B # C  
14/14 A # B # C # D  A # B # C # D  A # B # C # D  
28/06 A # B = C  A # B # C  NA 
02/03 A = B  A # B  NA 
12/07 A = B  A # B  A # B  
22/06 A # B  A # B  A # B  
08/03 A - B  A = B  A = B  
14/07 A # B # C Z D  A f B f C f D  B # D  
* A, B, C, and D are arbitrary codes for the successive clinical epidodes in each child. NA = not available. 
rapidly resulting in a negative blood ?mear and disappear- 
ance of the alleles identified during the clinical attack, long- 
term carriage of parasites was precluded in these children. 
This indicates that clinical malaria episodes were induced by 
recently inoculated parasites. During the period under study, 
the mean inoculation rate was one infective bite every sec- 
ond night. With such a large local parasite diversity, inocu- 
lation of new strains should have been a frequent event. A 
longitudinal analysis of the strains harbored by children who 
remained asymptomatic (and thus untreated) during the same 
period showed successive waves of genetically distinct par- 
a s i t e~ . ’~  This rapid turnover of strains in the peripheral cir- 
culation was consistent with a frequent inoculation of new 
parasite populations. It is noteworthy that even under such 
an intense transmission, some children remained apparently 
free of parasites for long periods (up to two months), pre- 
senting negative blood smears and no evidence of parasites 
by PCR (neither by direct examination of the PCR product 
nor by hybridization). We do not know whether this absence 
of parasites indicates that these children did not receive any 
infective bite for several weeks or whether they had the ca- 
pacity to rapidly clear many strains, while still being fully 
susceptible to other ones. 
The genotypes of the parasites present in the peripheral 
circulation during the clinical episodes analyzed here were 
all different. This suggests that there is no precise pathogenic 
type, but rather that clinical attacks may be caused by a large 
number of distinct strains. For some children, the encounter 
with P. fakiparum parasites had a different outcome for dif- 
ferent strains. Indeed, one of the most important observa- 
tions was that in the children presenting alternating periods 
of symptomatic or asymptomatic carriage, the genetic char- 
acteristics of the parasites carried at low density during 
asymptomatic phases differed from those of the parasites 
causing a clinical episode, which quickly reached high par- 
asitemia. This indicates that the factors controlling parasite 
density in these children were strain-specific. This could re- 
flect differences in the growth rate of various strains, result- 
ing from the poor fitness of some types in certain hosts, such 
as, for instance, poor invasion efficiency, impaired intraer- 
ythrocytic maturation, or a slow replication rate, andfor re- 
flect specific immune pressure, which would restrict parasite 
multiplication of certain strains while leaving other strains 
unaffected. The hypothesis that strain-specific immune re- 
sponses participate in control of parasite density in semi- 
immune children is in agreement with the conclusions drawn 
from experimental infections in both primatesI7 and hu- 
m a n ~ . ~ .  This does not preclude the possibility that matura- 
tion of the immune response elicited by a specific strain a n d  
or exposure to additional strains subsequently results in pro- 
tective mechanisms transcending strain specificities. Eluci- 
dation of the respective contribution of strain-specific and 
nonspecific responses to control of parasite propagation is a 
key element in our understanding of protection against ma- 
laria. To date, this has been difficult to study because the 
immune effectors contributing to parasite clearance in hu- 
mans are unclear, and as a consequence, the target antigens 
of protective immune mechanisms are still to be determined. 
Several antigens presenting considerable serologic diversity 
have been described. The variant antigen located on the sur- 
face of the infected red blood cell elicits variant-specific im- 
mune responses.’8-20 While the contribution of such an an- 
tibody to parasite clearance remains to be demonstrated in 
humans, protection was shown to be variant-specific in Sai- 
miri monkeys.’O The large local allelic polymorphism of the 
MSA-1 and MSA-2 genes observed here and in a few other 
studies2I- 22 raises the interesting alternative that these major 
merozoite antigensz3. 24 could constitute strain-specific tar- 
gets. Investigation of the immune response of the children 
studied here to various allelic forms of these antigens is un- 
derway. 
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